Large-Scale Clinical-Grade Retroviral Vector Production in iCELLis Nano Bioreactor

被引：0
|
作者：
Wang, Xiuyan [1 ,3 ]
Olzzewska, Malgorzata [1 ]
Qu, Jinrong [1 ]
Wasielewska, Teresa [1 ]
Bartido, Shirley [1 ]
Hermetet, Gregory [4 ]
Sadelain, Michel [2 ,3 ]
Riviere, Isabelle [1 ,2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Cell Therapy & Cell Engn Facil, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA
[4] ATMI Life Sci, Allston, MA USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
50
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [41] Lentiviral/retroviral vector large scale manufacturing
    Bellintani, F.
    Neri, M.
    Rossetti, F.
    Cota, M.
    Crippa, L.
    Piovani, B.
    Simonetti, E.
    Allievi, L.
    Corbetta, S.
    Lorenzetti, F.
    Testasecca, A.
    Pedregal, A.
    Vallanti, G.
    HUMAN GENE THERAPY, 2018, 29 (12) : A158 - A159
  • [42] Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
    van der Loo, J. C. M.
    Swaney, W. P.
    Grassman, E.
    Terwilliger, A.
    Higashimoto, T.
    Schambach, A.
    Hacein-Bey-Abina, S.
    Nordling, D. L.
    Cavazzana-Calvo, M.
    Thrasher, A. J.
    Williams, D. A.
    Reeves, L.
    Malik, P.
    GENE THERAPY, 2012, 19 (08) : 872 - 876
  • [43] Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
    J C M van der Loo
    W P Swaney
    E Grassman
    A Terwilliger
    T Higashimoto
    A Schambach
    S Hacein-Bey-Abina
    D L Nordling
    M Cavazzana-Calvo
    A J Thrasher
    D A Williams
    L Reeves
    P Malik
    Gene Therapy, 2012, 19 : 872 - 876
  • [44] Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies
    Przybylowski, Mark
    Bartido, Shirley
    Borquez-Ojeda, Oriana
    Sadelain, Michel
    Riviere, Isabelle
    VACCINE, 2007, 25 (27) : 5013 - 5024
  • [45] A NOVEL-APPROACH TO THE PRODUCTION OF CLINICAL-GRADE DEXTRAN
    BARKER, PE
    GANETSOS, G
    AJONGWEN, NJ
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 1993, 57 (01) : 21 - 26
  • [46] Lentiviral/retroviral vector manufacturing production using disposable fixed-bed bioreactors iCELLis® system
    Neri, M.
    Bellintani, F.
    Cota, M.
    Crippa, L.
    Brunati, M.
    Piovani, B.
    Allievi, L.
    Testasecca, A.
    Pedregal, A.
    Gatti, A.
    Rossetti, F.
    Vallanti, G.
    HUMAN GENE THERAPY, 2017, 28 (12) : A117 - A118
  • [47] Optimization of Cell Inoculation and Distribution in iCELLis Nano Bioreactors for Improved Viral Vector Production
    Santiago-Ortiz, Jorge
    Ciasullo, Gabriella
    Martinez-Goyco, Joel
    Olson, Michelle
    MacIntyre, Anne
    MOLECULAR THERAPY, 2022, 30 (04) : 537 - 537
  • [48] Polymersomes for biotechnological applications: Large-scale production of nano-scale vesicles
    Poschenrieder, Sarah Theresa
    Schiebel, Sina Katharina
    Castiglione, Kathrin
    ENGINEERING IN LIFE SCIENCES, 2017, 17 (01): : 58 - 70
  • [49] CYTOTOXIN PRODUCTION BY A MARINE LYNGBYA STRAIN (CYANOBACTERIUM) IN A LARGE-SCALE LABORATORY BIOREACTOR
    ARMSTRONG, JE
    JANDA, KE
    ALVARADO, B
    WRIGHT, AE
    JOURNAL OF APPLIED PHYCOLOGY, 1991, 3 (03) : 277 - 282
  • [50] Efficient gene transfer into human primitive hematopoietic progenitor cells by a pharmaceutical grade serum-free retroviral vector medium and its large-scale GMP-production.
    Glimm, H
    Klingenberg, S
    Flugge, K
    Hofmann, VM
    Lange, W
    Mertelsmann, R
    VonKalle, C
    BLOOD, 1997, 90 (10) : 4643 - 4643
12345